In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medivance completes $23m financing round:

This article was originally published in Clinica

Executive Summary

Therapeutic temperature management firm Medivance has sealed a series D financing round worth $23m. Existing investors Cross Atlantic Partners, Camden Partners, Skyline Ventures and Partisan Management combined with new shareholder MDY Healthcare to contribute the funds. The proceeds will be channelled towards the development of the company's Arctic Sun therapeutic cooling system and other new products. The Arctic Sun is becoming established in treating the brain after stroke, cardiac arrest, fever, trauma and other critical conditions, claims the Louisville, Colorado firm.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts